Picture of Addex Therapeutics logo

ADXN Addex Therapeutics News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Swiss stocks - Factors to watch on December 15

ZURICH/BERLIN, Dec 15 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Tuesday:
    
    CORONAVIRUS
    The World Health Organization is aware of a new variant of
COVID-19 that has emerged in Britain, but there is no evidence
the strain behaves differently to existing types of the virus,
it said.  urn:newsml:reuters.com:*:nZ8N2FE021
    Moderna  MRNA.O  said it was informed by the European
Medicines Agency certain documents related to pre-submission
talks of its COVID-19 vaccine candidate were unlawfully accessed
in a cyberattack on the medicines regulator.  urn:newsml:reuters.com:*:nL4N2IU4JE
    Asian stocks drifted lower as worries about increasing
COVID-19 deaths and lockdowns overshadowed optimism about the
roll-out of coronavirus vaccinations.  urn:newsml:reuters.com:*:nL1N2IV00T
     London will move into England's highest tier of COVID-19
restrictions, the government said, citing increased infection
rates that may be partly linked to a new variant of the
coronavirus.  urn:newsml:reuters.com:*:nL8N2IU2LH
    
      
    CREDIT SUISSE  CSGN.S 
    Credit Suisse Chief Executive Thomas Gottstein provides his
first outlook to the bank's shareholders.
    
    
    COMPANY STATEMENTS
    * Roche  ROG.S : The FDA has approved Roche's Ocrevus
shorter 2-hour infusion for relapsing and primary progressive
multiple sclerosis  urn:newsml:reuters.com:*:nASN000MTE
    * Schindler  SCHP.S  has decided to appoint Tobias B.
Staehelin as a member of group executive committee responsible
for human resources with effect from April 1, 2021.  urn:newsml:reuters.com:*:nFWN2IU1BZ
    * Implenia  IMPN.S : wins full-service-provider competition
and contract to renovate UBS Paradeplatz as total contractor
 urn:newsml:reuters.com:*:nASN000MT8
    * Burckhardt Compression  BCHN.S : Shareholders have decided
ahead of schedule to again enter into a new five-year
shareholders' agreement with a term until May 2026  urn:newsml:reuters.com:*:nFWN2IU1C0
    * Addex  ADXN.S : announced filing of registration statement
for proposed public offering of securities  urn:newsml:reuters.com:*:nASA01I81

    
    ECONOMY
    Swiss government's economic forecast due at 0645 GMT
    Swiss November producer and import prices due at 0730 GMT

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))

Recent news on Addex Therapeutics

See all news